Press Releases

CD Genomics Releases Human Mitochondrial DNA Sequencing for Disease Research and Biodiversity Assessment

Genovac further enhances its antibody discovery services with the ENPICOM IGX Platform

ENPICOM has announced that Genovac will use its IGX Platform for its antibody discovery workflows.

Independent study validates HORIBA Medical’s Yumizen G DDi 2 assay for rapid D-dimer quantification

HORIBA Medical’s D-dimer immunoassay displays excellent analytical performance in independent evaluation study

Biotium Announces Acquisition of CAT5™ FFPE RNA/DNA Extraction Technology from Cell Data Sciences

Biotium is announcing the acquisition of Cell Data Sciences RNAstorm™ and DNAstorm™ kits for RNA/DNA extraction.

Creative Bioarray Provides Expertise in Delivering Comprehensive Pain Models to Support Pain Studies

Creative Bioarray Supplies Comprehensive Products to Support The Needs of Cell Culture Applications

DDA Platform Delivers Metabolic Stability Services to Accelerate Drug Discovery Procedures

Creative Biogene Generates Professional Cell Expression System to Accelerate Bioproduction Stable Cell Line Development

Qvirus Platform Optimized Lentivirus Production System for The Efficient design and Development of Lentivirus Vector

Microbiosci Develops Strain Selection and Fermentation Services to Accelerate The Development of Microbial Technologies

CD Formulation Newly Launches Drug Packaging Services for the Pharmaceutical Industry

Packaging is another factor that decides the stability and integrity of drugs. Except for the role as an excipient producer and supplier, the US-based CRO company CD Formulation today announces that it newly launches a wide range of pharmaceutical packaging services, providing support throughout the whole process of packaging design, from material selection to chemical and surface analysis and to design selection.

Alfa Chemistry: Polymer Surfactants Have Exceptional Properties

With broad use in the manufacture of cleaning, pharmaceutical, cosmetic, and food products, the significance of polymer surfactants can never be neglected. In a recent statement, Alfa Chemistry announced the supply of a wide range of polymer surfactants for potential uses in both scientific research and industrial manufacturing.

CD Formulation Enriches Its Supply of Active Pharmaceutical Ingredient Excipients

Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. Now a number of API excipients are readily obtainable at CD Formulation, including Cetrorelix Acetate, Fondaparinux Sodium, Calcitriol, Vitamine D3, Tirofiban Hydrochloride, Eptifibatide, Ferric Ammonium Citrate, Calcipotriol API, Calcium Orotate, Meglumine, Obeticholic Acid, Potassium Magnesium Citrate and Magnesium Oxide.

Alfa Chemistry: Photochromic Materials Exhibit Intriguing Optical Properties

Earlier this month, Alfa Chemistry Materials announces the offering of photochromic materials, a material characterized by its optical properties being able to change reversibly upon irradiation. In fact, this company, reputed for the supply of all kinds of materials, has previously launched a wide array of other functional materials such as charge transfer complexes, macrocycles, phthalonitriles & naphthalonitriles, pressure & heat sensitive recording materials, semiconducting materials, silane coupling agents, and UV absorbents.

Lung cancer test could identify high-risk patients before symptoms

A new diagnostic test for lung cancer could identify high-risk patients even before the onset of symptoms. Cscreen+ will provide an annual lung cancer screening test for high-risk smokers aged 45 and older using lateral flow technology. It will allow rapid early diagnosis and intervention, potentially saving thousands of lives and significantly reducing costs of diagnosis and care associated with late-stage disease. The test is being brought to market by iOmics Ltd., a diagnostics company based in Wales.

Accelerating Peptide Drug Research with Creative Peptides’ Premade Peptide Library

Creative Peptides constructed a versatile total peptide library with its proprietary peptide design platform to accelerate peptide drug research.

BOC Sciences Unveils Comprehensive Custom Synthesis Services

BOC Sciences unveils its comprehensive custom synthesis services for worldwide partners engaged in biopharmaceutical, chemical, and life science research.

Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe

Panthera Biopartners has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment round will be used to fund further expansion in the UK and Western Europe.

DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

Globally Recognized Scientific Policy and Genomics Expert Genya Dana, Ph.D. Joins Avellino as Global Head of Health Policy

Avellino Lab USA, Inc. today announced Genya Dana, Ph.D., as Global Head of Health Policy for the company. Genya comes to Avellino from the World Economic Forum, where she served as its Head of Healthcare.